Outcomes of patients with double/triple expressor diffuse large B-cell lymphoma (DLBCL) treated with R-DA-EPOCH/R-CHOP: A single-center experience.
In Pakistan 76.4% of all NHLs to be diagnosed as DLBCLs. The survival of R-CHOP is better compared to the DA-REPOCH treatment regimen. A prospective follow-up study was conducted with 113 patients to study the outcomes of treatment. Multivariable cox-proportional hazard model was used to estimate th...
Guardado en:
Autores principales: | Kanta Devi, Muhammad Usman Shaikh, Natasha Bahadur Ali, Salman Naseem Adil, Maria Khan, Salman Muhammad Soomar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/df0abb92c51246bdb91afa4e4eef1f91 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparación entre CHOP-like y R-CHOP en pacientes con linfoma no Hodgkin difuso de grandes células B y folicular: 10 años de experiencia del Hospital de Clínicas de Montevideo, Uruguay
por: Oliver,Carolina, et al.
Publicado: (2013) -
Prognostic analysis of CD5 expression in double-hit diffuse large B-cell lymphoma and effectiveness comparison in patients treated with dose-adjusted EPOCH plus rituximab/R-CHOP regimens
por: Zhang F, et al.
Publicado: (2019) -
Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India
por: Ajay Gogia, et al.
Publicado: (2021) -
Evolución de un linfoma no Hodgkin “triple expresor” en un paciente trasplantado renal con quimioterapia DA-R-EPOCH. Caso clínico
por: Aránguiz,Natalia, et al.
Publicado: (2019) -
Ocurrencia de leucemia mieloide crónica y linfoma no Hodgkin en un mismo paciente: Caso clínico
por: Morales F,Eugenia, et al.
Publicado: (1999)